Patents by Inventor Nancy Cherry WHITING

Nancy Cherry WHITING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
    Publication number: 20220265844
    Abstract: Anti-TF antibody drug conjugate and pharmaceutical compositions comprising the antibody drug-conjugate for use in the treatment of a solid cancer comprising administering to a subject a weekly dose of from about 0.8 mg/kg to about 1.8 mg/kg of an anti-TF antibody drug conjugate once a week for three consecutive weeks followed by a one week resting period without any administration of anti-TF ADC so that each cycle time is 28 days including the resting period.
    Type: Application
    Filed: December 10, 2021
    Publication date: August 25, 2022
    Inventors: Steen LISBY, Nancy Cherry WHITING
  • DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
    Publication number: 20190030178
    Abstract: Anti-TF antibody drug conjugate and pharmaceutical compositions comprising the antibody drug-conjugate for use in the treatment of a solid cancer comprising administering to a subject a weekly dose of from about 0.8 mg/kg to about 1.8 mg/kg of an anti-TF antibody drug conjugate once a week for three consecutive weeks followed by a one week resting period without any administration of anti-TF ADC so that each cycle time is 28 days including the resting period.
    Type: Application
    Filed: September 9, 2016
    Publication date: January 31, 2019
    Applicant: Genmab A/S
    Inventors: Steen LISBY, Nancy Cherry WHITING